bromazepam has been researched along with Obesity in 1 studies
Bromazepam: One of the BENZODIAZEPINES that is used in the treatment of ANXIETY DISORDERS.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Xie, X | 1 |
Yang, H | 1 |
An, JJ | 1 |
Houtz, J | 1 |
Tan, JW | 1 |
Xu, H | 1 |
Liao, GY | 1 |
Xu, ZX | 1 |
Xu, B | 1 |
1 other study available for bromazepam and Obesity
Article | Year |
---|---|
Activation of Anxiogenic Circuits Instigates Resistance to Diet-Induced Obesity via Increased Energy Expenditure.
Topics: Adipose Tissue; Animals; Anti-Anxiety Agents; Body Weight; Bromazepam; Carbolines; Diet; Energy Meta | 2019 |